Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Murad

This article was originally published in The Tan Sheet

Executive Summary

Murad: Antioxidant vitamin supplements taken in combination with SPF-15 sunscreens increase SPF value by 8-10%, according to a study sponsored by the Manhattan Beach, Calif.-based skin care firm. Conducted by Consumer Product Testing Co., the 10-person study evaluated the potential of Murad's antioxidant supplements "to change photobiological responsiveness in human subjects." Over a seven-day period, participants received separate applications of three Murad sun care products, were given antioxidant supplements twice daily and exposed to UV light. At the end of the week, a 7.9% boost in SPF value was recorded for the company's Murasun Daily Sunblock and a 10.4% increase for its Murasun Daily Sunscreen product. Murad announced earlier this year its plans to launch the antioxidant supplement line in May...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS085587

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel